| CVSS Meta Temp Score | Current Exploit Price (≈) | CTI Interest Score |
|---|---|---|
| 4.3 | $0-$5k | 0.00 |
Summary
A vulnerability labeled as problematic has been found in Open-Xchange AppSuite up to 7.4.1. The impacted element is an unknown function. The manipulation results in cross site scripting. This vulnerability is identified as CVE-2013-7142. The attack can be executed remotely. There is not any exploit available.
Details
A vulnerability, which was classified as problematic, was found in Open-Xchange AppSuite up to 7.4.1 (Groupware Software). Affected is an unknown part. The manipulation with an unknown input leads to a cross site scripting vulnerability. CWE is classifying the issue as CWE-79. The product does not neutralize or incorrectly neutralizes user-controllable input before it is placed in output that is used as a web page that is served to other users. This is going to have an impact on integrity. CVE summarizes:
Cross-site scripting (XSS) vulnerability in Open-Xchange (OX) AppSuite 7.4.1 and earlier allows remote attackers to inject arbitrary web script or HTML via unspecified oAuth API functions.
The weakness was released 01/26/2014 with Open-Xchange (Website). The advisory is shared for download at seclists.org. This vulnerability is traded as CVE-2013-7142 since 12/18/2013. It is possible to launch the attack remotely. The exploitation doesn't require any form of authentication. Successful exploitation requires user interaction by the victim. There are neither technical details nor an exploit publicly available. The MITRE ATT&CK project declares the attack technique as T1059.007.
There is no information about possible countermeasures known. It may be suggested to replace the affected object with an alternative product.
The vulnerability is also documented in the databases at X-Force (90545), SecurityFocus (BID 65012†) and OSVDB (102193†). Entries connected to this vulnerability are available at VDB-66217, VDB-66215 and VDB-66214. VulDB is the best source for vulnerability data and more expert information about this specific topic.
Product
Type
Vendor
Name
Version
License
Website
- Vendor: https://www.open-xchange.com/
CPE 2.3
CPE 2.2
CVSSv4
VulDB Vector: 🔍VulDB Reliability: 🔍
CVSSv3
VulDB Meta Base Score: 4.3VulDB Meta Temp Score: 4.3
VulDB Base Score: 4.3
VulDB Temp Score: 4.3
VulDB Vector: 🔍
VulDB Reliability: 🔍
CVSSv2
| AV | AC | Au | C | I | A |
|---|---|---|---|---|---|
| 💳 | 💳 | 💳 | 💳 | 💳 | 💳 |
| 💳 | 💳 | 💳 | 💳 | 💳 | 💳 |
| 💳 | 💳 | 💳 | 💳 | 💳 | 💳 |
| Vector | Complexity | Authentication | Confidentiality | Integrity | Availability |
|---|---|---|---|---|---|
| Unlock | Unlock | Unlock | Unlock | Unlock | Unlock |
| Unlock | Unlock | Unlock | Unlock | Unlock | Unlock |
| Unlock | Unlock | Unlock | Unlock | Unlock | Unlock |
VulDB Base Score: 🔍
VulDB Temp Score: 🔍
VulDB Reliability: 🔍
NVD Base Score: 🔍
Exploiting
Class: Cross site scriptingCWE: CWE-79 / CWE-94 / CWE-74
CAPEC: 🔍
ATT&CK: 🔍
Physical: No
Local: No
Remote: Yes
Availability: 🔍
Status: Not defined
EPSS Score: 🔍
EPSS Percentile: 🔍
Price Prediction: 🔍
Current Price Estimation: 🔍
| 0-Day | Unlock | Unlock | Unlock | Unlock |
|---|---|---|---|---|
| Today | Unlock | Unlock | Unlock | Unlock |
Threat Intelligence
Interest: 🔍Active Actors: 🔍
Active APT Groups: 🔍
Countermeasures
Recommended: no mitigation knownStatus: 🔍
0-Day Time: 🔍
Timeline
12/18/2013 🔍01/17/2014 🔍
01/26/2014 🔍
01/26/2014 🔍
03/24/2015 🔍
01/31/2022 🔍
Sources
Vendor: open-xchange.comAdvisory: seclists.org
Organization: Open-Xchange
Status: Not defined
CVE: CVE-2013-7142 (🔍)
GCVE (CVE): GCVE-0-2013-7142
GCVE (VulDB): GCVE-100-66216
X-Force: 90545
SecurityFocus: 65012 - Open-Xchange AppSuite 'oAuth' API Cross Site Scripting Vulnerability
OSVDB: 102193
SecurityTracker: 1029650
See also: 🔍
Entry
Created: 03/24/2015 15:54Updated: 01/31/2022 20:35
Changes: 03/24/2015 15:54 (50), 03/06/2019 15:33 (4), 01/31/2022 20:35 (3)
Complete: 🔍
Cache ID: 216:DDF:103
VulDB is the best source for vulnerability data and more expert information about this specific topic.
No comments yet. Languages: en.
Please log in to comment.